[1] |
CAO Xiaoshan, YANG Beibei, CONG Binbin, LIU Hong.
The progress of treatment for brain metastases of triple-negative breast cancer
[J]. China Oncology, 2024, 34(8): 777-784.
|
[2] |
CHEN Junyao, ZHANG Wentao, LIU Qiao, NIE Jianyun.
Clinical dilemma and systemic treatment strategy of triple-negative breast cancer in the elderly
[J]. China Oncology, 2023, 33(5): 506-516.
|
[3] |
SHAO Zhibo, YANG Benlong, WU Jiong.
Progress of important clinical trials of breast cancer in China in 2022
[J]. China Oncology, 2023, 33(2): 103-109.
|
[4] |
XIAO Yuling, ZHU Xiuzhi, JIANG Yizhou, SHAO Zhimin.
New research advances and future prospect in precision treatment of triple-negative breast cancer
[J]. China Oncology, 2022, 32(8): 669-679.
|
[5] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[6] |
JIANG Mengyi , LU Yanqiao , WANG Hongxia .
Research progress and clinical significance of breast cancer heterogeneity
[J]. China Oncology, 2020, 30(5): 394-400.
|
[7] |
SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng .
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
[J]. China Oncology, 2020, 30(3): 186-191.
|
[8] |
ZHAO Yudi, TAN Fang, YAN Zhiling, LI Yingfu, DAI Shuying, ZHOU Ziyun, ZHANG Xinwen, LIU Shuyuan, SHI Li, YAO Yufeng.
Correlation between genetic variants in CD44 gene and cervical cancer and non-small cell lung cancer
[J]. China Oncology, 2019, 29(4): 277-283.
|
[9] |
CAO Xiaoshan, CONG Binbin.
The progress of treatment for triple-negative breast cancer in the era of precision medicine
[J]. China Oncology, 2019, 29(12): 971-976.
|
[10] |
ZHU Xiuzhi, CHEN Li, JI Lei, GAO Yu, WANG Zhonghua.
Advances in the treatment of triple-negative breast cancer with CDK4/6 inhibitors
[J]. China Oncology, 2019, 29(11): 899-905.
|
[11] |
ZHENG Xiaying, CHEN Junxia.
Expression of circRNA hsa_circ_0005320 in triple-negative breast cancer and its effect on cell proliferation
[J]. China Oncology, 2019, 29(11): 845-854.
|
[12] |
LI Jiawei, SHI Zhaoting, HOU Yingmin, et al.
Clinicopathological and immunohistochemical basis for sonographic characteristics of triple-negative invasive breast cancer
[J]. China Oncology, 2019, 29(1): 37-44.
|
[13] |
YANG Rui, CHEN Junxia.
Effects of circular RNA hsa_circ_0058514 on the development and progression of triple-negative breast cancer
[J]. China Oncology, 2019, 29(1): 9-18.
|
[14] |
JI Peng, GONG Yue, DI Genhong.
Latest research progress on tumor-infiltrating lymphocytes in HER2-positive and triple-negative breast cancer
[J]. China Oncology, 2018, 28(12): 928-934.
|
[15] |
LIU Zimei, YU Wenxi, SUN Chu, et al.
Clinical significance of ICAM-1 expression and its correlation with prognosis of triple-negative breast cancer
[J]. China Oncology, 2017, 27(2): 121-127.
|